Skip to Content

Pazeo Approval History

FDA Approved: Yes (First approved January 30, 2015)
Brand name: Pazeo
Generic name: olopatadine hydrochloride
Dosage form: Ophthalmic Solution
Company: Alcon
Treatment for: Conjunctivitis, Allergic

Pazeo (olopatadine hydrochloride) is a mast cell stabilizer for the treatment of ocular itching associated with allergic conjunctivitis.

Development History and FDA Approval Process for Pazeo

DateArticle
Feb  2, 2015Approval Alcon Receives FDA Approval of Pazeo (olopatadine HCl) Ophthalmic Solution for Allergic Conjunctivitis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide